We showed that NF-κB p65 in the nucleus of prostate cancer cells was associated with all evaluated prostate cancer endpoints (biochemical recurrence, development of bone metastases, and prostate-cancer-specific death). The gene discussed is NFKB1; the disease is prostate carcinoma.